SE9702793D0 - Novel formulation - Google Patents
Novel formulationInfo
- Publication number
- SE9702793D0 SE9702793D0 SE9702793A SE9702793A SE9702793D0 SE 9702793 D0 SE9702793 D0 SE 9702793D0 SE 9702793 A SE9702793 A SE 9702793A SE 9702793 A SE9702793 A SE 9702793A SE 9702793 D0 SE9702793 D0 SE 9702793D0
- Authority
- SE
- Sweden
- Prior art keywords
- novel formulation
- novel
- formulation
- medicament
- ion
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
Priority Applications (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9702793A SE9702793D0 (sv) | 1997-07-24 | 1997-07-24 | Novel formulation |
| ARP980103399A AR018002A1 (es) | 1997-07-24 | 1998-07-13 | Composicion farmaceutica que comprende un anticonvulsivo y una resina de intercambio ionico para el tratamiento de la epilepsia, compuestos, uso de lapirrolidona polivinilica y proceso para preparar la composicion |
| ZA9806213A ZA986213B (en) | 1997-07-24 | 1998-07-13 | Formulation comprising an anticonvulsant and an ion-exchange resin. |
| AU83710/98A AU8371098A (en) | 1997-07-24 | 1998-07-17 | Pharmaceutical formulation comprising a 2-aminoacetamide derivative and an ion exchange resin |
| JP2000503836A JP2001510798A (ja) | 1997-07-24 | 1998-07-17 | ２−アミノアセトアミド誘導体およびイオン交換樹脂から成る医薬製剤 |
| EP98934112A EP1009396B1 (en) | 1997-07-24 | 1998-07-17 | Pharmaceutical formulation comprising a 2-aminoacetamide derivative and an ion exchange resin |
| PCT/SE1998/001398 WO1999004779A1 (en) | 1997-07-24 | 1998-07-17 | Pharmaceutical formulation comprising a 2-aminoacetamide derivative and an ion exchange resin |
| US09/180,134 US6193962B1 (en) | 1997-07-24 | 1998-07-17 | Pharmaceutical formulation comprising a 2-aminoacetamide derivative and an ion exchange resin |
| DE69804324T DE69804324T2 (de) | 1997-07-24 | 1998-07-17 | Pharmazeutische formulierung mit einem 2-aminoacetamidderivat und einem ionenaustauscherharz |
| AT98934112T ATE214600T1 (de) | 1997-07-24 | 1998-07-17 | Pharmazeutische formulierung mit einem 2- aminoacetamidderivat und einem ionenaustauscherharz |
| MYPI98003361A MY120751A (en) | 1997-07-24 | 1998-07-22 | Pharmaceutical formulation comprising a 2-aminoacetamide derivative and an ion exchange resin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9702793A SE9702793D0 (sv) | 1997-07-24 | 1997-07-24 | Novel formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE9702793D0 true SE9702793D0 (sv) | 1997-07-24 |
Family
ID=20407822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE9702793A SE9702793D0 (sv) | 1997-07-24 | 1997-07-24 | Novel formulation |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6193962B1 (sv) |
| EP (1) | EP1009396B1 (sv) |
| JP (1) | JP2001510798A (sv) |
| AR (1) | AR018002A1 (sv) |
| AT (1) | ATE214600T1 (sv) |
| AU (1) | AU8371098A (sv) |
| DE (1) | DE69804324T2 (sv) |
| MY (1) | MY120751A (sv) |
| SE (1) | SE9702793D0 (sv) |
| WO (1) | WO1999004779A1 (sv) |
| ZA (1) | ZA986213B (sv) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4041309A4 (en) * | 2019-10-10 | 2023-11-01 | Brillian Pharma Inc. | PHARMACEUTICAL COMPOSITION BASED ON MICRONIZED ACTIVE RESINATE AND METHOD FOR THE PRODUCTION THEREOF |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB857194A (en) * | 1957-07-05 | 1960-12-29 | Clinical Products Ltd | Therapeutic agents comprising ion-exchange resins |
| US3100738A (en) * | 1961-08-09 | 1963-08-13 | Neisler Lab Inc | Uniform release process |
| US4714620A (en) | 1986-12-12 | 1987-12-22 | Warner-Lambert Company | Soft, sugarless aerated confectionery composition |
| IL84305A (en) | 1987-02-06 | 1992-01-15 | Fisons Corp | 2-aminoacetamide derivatives |
| ZA908490B (en) | 1989-10-27 | 1991-07-31 | Fisons Corp | Use of arylalkylamides in the treatment of neurodegenerative diseases |
| US5188825A (en) | 1989-12-28 | 1993-02-23 | Iles Martin C | Freeze-dried dosage forms and methods for preparing the same |
| GB9104042D0 (en) | 1991-02-26 | 1991-04-10 | Abbott Lab | Taste-masked buflomedil preparation |
| FR2676364B1 (fr) | 1991-05-17 | 1993-09-10 | Lafon Labor | Composition pharmaceutique a base de derives d'aminobutanone. |
| SE9103110D0 (sv) * | 1991-10-24 | 1991-10-24 | Kabi Pharmacia Ab | New drug formulation |
| JP3207494B2 (ja) * | 1992-04-02 | 2001-09-10 | ロート製薬株式会社 | 水性懸濁製剤 |
| US5455049A (en) | 1995-01-04 | 1995-10-03 | Ascent Pharmaceuticals, Inc. | Terfenadine oral powder |
-
1997
- 1997-07-24 SE SE9702793A patent/SE9702793D0/sv unknown
-
1998
- 1998-07-13 AR ARP980103399A patent/AR018002A1/es not_active Application Discontinuation
- 1998-07-13 ZA ZA9806213A patent/ZA986213B/xx unknown
- 1998-07-17 DE DE69804324T patent/DE69804324T2/de not_active Expired - Fee Related
- 1998-07-17 JP JP2000503836A patent/JP2001510798A/ja active Pending
- 1998-07-17 AU AU83710/98A patent/AU8371098A/en not_active Abandoned
- 1998-07-17 EP EP98934112A patent/EP1009396B1/en not_active Expired - Lifetime
- 1998-07-17 AT AT98934112T patent/ATE214600T1/de not_active IP Right Cessation
- 1998-07-17 US US09/180,134 patent/US6193962B1/en not_active Expired - Fee Related
- 1998-07-17 WO PCT/SE1998/001398 patent/WO1999004779A1/en active IP Right Grant
- 1998-07-22 MY MYPI98003361A patent/MY120751A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69804324D1 (de) | 2002-04-25 |
| AR018002A1 (es) | 2001-10-31 |
| EP1009396B1 (en) | 2002-03-20 |
| MY120751A (en) | 2005-11-30 |
| DE69804324T2 (de) | 2003-02-27 |
| US6193962B1 (en) | 2001-02-27 |
| JP2001510798A (ja) | 2001-08-07 |
| AU8371098A (en) | 1999-02-16 |
| EP1009396A1 (en) | 2000-06-21 |
| ZA986213B (en) | 2000-01-13 |
| ATE214600T1 (de) | 2002-04-15 |
| WO1999004779A1 (en) | 1999-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69419519D1 (de) | Riechstoffe formulierungen | |
| TR199501325A2 (tr) | Protez dis sabitlestirme terkipleri. | |
| HN1999000066A (es) | Formulaciones farmaceuticas | |
| FR2705356B1 (fr) | Compositions d'adhésif de pression de silicone. | |
| DK1047740T3 (da) | Hærdelige harpikssammensætninger | |
| DE69021387D1 (de) | Medizinische aerosolformulierungen. | |
| BR9610153A (pt) | Formulações farmacêuticas | |
| DZ2026A1 (fr) | Compositions vaccinantes. | |
| DE69831796D1 (de) | Flammhemmende harzzusammensetzungen | |
| EE9800123A (et) | Stabiilsed lüofiliseeritud ravimvormid | |
| ATE236617T1 (de) | Aerosol-arzneiformulierungen | |
| DE68911473D1 (de) | Arzneimittelformulierungen. | |
| DK67795A (da) | Insulinanalog-formuleringer | |
| DE69817924D1 (de) | Superabsorbierende Harzzusammensetzung | |
| NO901002D0 (no) | Lavkostnads vaatt-til-vaatt trykkavfoelerpakke. | |
| DZ1835A1 (fr) | Nouvelles formulations. | |
| HN1998000124A (es) | Terapia de combinacion | |
| DE69835287D1 (de) | Halogenierte harzzusammensetzungen | |
| DE69431344D1 (de) | Selbstbräunendes kosmetikpräparat | |
| DE69227976D1 (de) | Amphotere Zusammensetzungen | |
| TR199501082A2 (tr) | Farmasötik formülasyonlar. | |
| HN1998000045A (es) | Composiciones farmaceuticas | |
| DE68918483D1 (de) | Wasserquellfähige Harzzusammensetzung. | |
| ITMI941169A0 (it) | Formulazioni farmaceutiche | |
| DE69831737D1 (de) | Neurotrypsin |